Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03261986
Other study ID # 17-066
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 9, 2017
Est. completion date February 9, 2022

Study information

Verified date March 2020
Source Midwest Orthopaedics at Rush
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to use radiostereometric analysis (RSA) and clinical outcome measures to evaluate early post-operative implant stability and the clinical performance of Stryker's Trident II Acetabular Cup.


Description:

The proposed study is a prospective evaluation of data from patients undergoing primary total hip arthroplasty using the Trident II acetabular cup. Fifty patients will be recruited for this study. All patients that qualify for the study per the inclusion-exclusion criteria and provide written informed consent will receive the Trident II acetabular cup and RSA beads. Implant stability, through RSA, will be measured throughout the first two postoperative (post-op) years per the following schedule: immediate post-op and 6 weeks, 3 months, 6 months, 1 year, and 2 years following surgery. Patients will be discharged and seen for follow-up assessments as per standard of care. Adverse events that are related to the index joint will be collected. Health outcome questionnaires will be collected. The health outcome questionnaires will include: EQ-5D, HOOS JR and Harris Hip Score. Health outcome questionnaires will be completed pre-operatively and again at 6 weeks, 3 months, 6 months, 1 year and 2 years following surgery. Conventional x-ray analysis will be performed pre-operatively and again at 6 weeks, 1 year and 2 years following surgery.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50
Est. completion date February 9, 2022
Est. primary completion date October 9, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

1. Symptomatic arthritis of the hip indicating surgical intervention

2. Scheduled to undergo a primary total hip arthroplasty

3. Patient is a candidate for the Trident II acetabular cup in accordance with product labeling -

Exclusion Criteria:

1. Patients less than 18 years of age, or older than 85 years of age.

2. Severe hip dysplasia (Crowe Type III or IV) in the affected hip

3. History of congenital dislocation

4. Prior arthroplasty of the affected hip

5. Active or prior infection of the affected hip

6. Morbid obesity (BMI > 40)

7. Medical condition precluding major surgery

8. Severe osteoporosis

9. Neuromuscular impairment

10. Patients with known allergy to metals

11. Pregnancy

12. Patients on dialysis or creatinine > 2.0

13. Patient is immuno-suppressed -

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
Radiostereometric Analysis
RSA exams of the operative hip are received post-op day 1, and at 6 weeks, 3 months, 6 months, 1 year and 2 years following surgery
Procedure:
total hip arthroplasty with RSA bead implantation
Patients receive RSA beads inserted into the bone surrounding the Trident II implant.

Locations

Country Name City State
United States Midwest Orthopaedics at Rush Naperville Illinois

Sponsors (1)

Lead Sponsor Collaborator
Midwest Orthopaedics at Rush

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Does the Trident II Cup achieve acceptable fixation to the underlying bone? The Trident II Cup proximal migration will be assessed. Migration of less than 0.2mm at 2 years and without continuous migration between post-operative year 1 and 2 will indicate acceptable fixation. 3 years
Secondary What are the migration patterns of the Trident II acetabular cup over the first two post-operative years? Migration patterns will be assessed using RSA analysis. 3 years
Secondary Is there a significant difference in health status and functional outcome before and after hip arthroplasty using Trident II Cup? The health status and functional outcome will be assessed via Harris Hip Score. 3 years
Secondary Is there a significant difference in health status and functional outcome before and after hip arthroplasty using Trident II Cup? The health status and functional outcome will be assessed via EQ-5D. 3 years
Secondary Is there a correlation between radiolucent lines measured by Charnley-DeLee zone analysis and migration characteristics using RSA? X-ray radiographs will be taken at pre-op, 6 weeks, 1 year and 2 year appointments. It may take up to 3 years after study start for all patients to reach the 2 year visit mark, depending on how long enrollment takes. 3 years
Secondary Can inducible displacements measured at 1 year post-operative distinguish patients identified by RSA measurements as having inadequate fixation? Inducible displacements will be measured using RSA exams at the 1 year follow-up. It may take up to 2 years after study start for all patients to reach the 1 year visit mark, depending on how long enrollment takes. 2 years
See also
  Status Clinical Trial Phase
Terminated NCT02818894 - Spinal Anesthesia in Total Hip Arthroplasty Phase 4
Completed NCT02242201 - Total Hip Arthroplasty (THA) Lumbar Plexus Verses Periarticular Phase 4
Completed NCT02414542 - Minima Clinical Study
Completed NCT01817010 - Strength and Function Following Total Hip Arthroplasty N/A
Completed NCT01443975 - Clinical Evaluation on the Use of the X-pander Device N/A
Recruiting NCT05530174 - Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With a Fracture N/A
Recruiting NCT05530551 - Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA N/A
Recruiting NCT05054192 - Reliability and Validity of Modified Four Square Step Test
Recruiting NCT06141928 - Comparison of Three Different Surgical Approaches on the Functional Outcome After Total Hip Arthroplasty N/A
Recruiting NCT04492462 - The Impact of Two Different Physical Therapy Programs in the Rehabilitation of Patients Undergoing Anterior Approach Hip Replacement Surgery N/A
Withdrawn NCT02926651 - Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty Phase 4
Completed NCT02308813 - Predictability of the Ability to Perform an Emergency Stop With Disorders of the Hip N/A
Recruiting NCT02032017 - Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation. N/A
Recruiting NCT01312077 - The Analgesic Efficacy of Periarticular Infiltration of Local Anaesthetic for Total Hip Replacement Phase 4
Withdrawn NCT01380665 - Prevena™ Incision Management System Over Primarily Closed Hip and Knee Incisions in Patients Immediately Post Total Hip and Knee Arthroplasty Phase 4
Recruiting NCT05893563 - Corail Stability at 5-Years Post-Total Hip Arthroplasty
Recruiting NCT06088069 - Effect of Virtual Reality on Perioperative Anxiety, Stress and Pain in Total Hip Arthroplasty N/A
Active, not recruiting NCT03210844 - The Clinical Outcomes After Direct Anterior Approach and Microposterior Approach for Total Hip Arthroplasty N/A
Recruiting NCT04801680 - Mpact 3D Metal Cup PMS
Terminated NCT02006251 - Real-Time Instrument for Acetabular Shell Positioning